SONOMA PHARMACEUTICALS, INC. (SNOA) Total liabilities 2017–2026
SONOMA PHARMACEUTICALS, INC. (SNOA) total liabilities at each fiscal year-end, per SEC filings.
$10.9MFY2026 · since FY2017: $4.0M → $10.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $10.9M | +17.1% |
| FY2025 | $9.3M | +7.9% |
| FY2024 | $8.6M | +4.2% |
| FY2023 | $8.3M | -18.7% |
| FY2022 | $10.1M | +5.4% |
| FY2021 | $9.6M | +7.7% |
| FY2020 | $8.9M | +125.7% |
| FY2019 | $4.0M | +2.0% |
| FY2018 | $3.9M | -3.7% |
| FY2017 | $4.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice